Keywords: 1st-qtr, eps, rise, drug, cos, early, sales

11% 1st-Qtr EPS Rise From US Drug Cos

Article | 15 April 1996

Print This

Early sales from a batch of new products and gains, in particular, by cholesterol-lowering drugs will drive US pharmaceutical companies ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in